D'IETEREN GROUP/ BE0974259880 /
- - | Diff. - | Volumen | Geld03:01:05 | Brief03:01:05 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
215,80EUR | - | - Umsatz: - |
-Geld Vol: - | -Brief Vol: - | 10,86 Mrd.EUR | 1,83% | 21,76 |
GlobeNewswire
12:00
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combinatio...
GlobeNewswire
12:00
Xunlei Announces Unaudited Financial Results for the First Quarter Ended March 31, 2024
GlobeNewswire
12:00
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainl...
GlobeNewswire
12:00
LANZATECH ALERT: Bragar Eagel & Squire, P.C. Investigates De-SPAC Merger of LNZA and AMCI and Encour...
GlobeNewswire
12:00
SHIMMICK ALERT: Bragar Eagel & Squire, P.C. is Investigating Shimmick Corporation on Behalf of Shimm...
GlobeNewswire
12:00
INOTIV ALERT: Bragar Eagel & Squire, P.C. is Investigating Inotiv, Inc. on Behalf of Inotiv Stockhol...
GlobeNewswire
12:00
FUTUREFUEL ALERT: Bragar Eagel & Squire, P.C. is Investigating FutureFuel Corp. on Behalf of FutureF...
GlobeNewswire
12:00
South Rampart Pharma Publishes SRP-001's Unique Pain Relief Mechanism and Phase 1 Trial Results in S...
GlobeNewswire
12:00
More Viewers are Trading Down to Ad-supported TV, Propelling Growth for SVOD Ad-tiers and FAST Platf...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite